Novartis Compound definition

Novartis Compound means (i) a compound within a NOVARTIS Library and identified as a hit as defined in the Research Plan together with [CONFIDENTIAL TREATMENT REQUESTED] and (ii) any such hit compound which would not have been directly or indirectly discovered, conceived, designed, synthesized, or developed but for use of a compound described in clause (i) above; all to the extent and only to the extent that NOVARTIS now has or hereafter will have at all pertinent times the right to grant licenses, immunities or other rights to TREGA.
Sample 1
Novartis Compound means any compound, other than an Active Cubist Compound, or an Active Cubist Compound Derivative, owned or controlled by Novartis or obtained from a Third Party which is either (a) screened in a Validated Assay and has antibacterial activity against a Selected Target or (b) has antibacterial activity against a Selected Target (regardless of whether or not a Validated Assay was used to determine such antibacterial activity), and any derivative, isomer, analog or homolog thereof made or synthesized by Novartis.
Sample 1
Novartis Compound means any Compound contained within a Novartis Chemotype.
Sample 1

Examples of Novartis Compound in a sentence

  • Novartis will pay royalties per Product being or containing a Novartis Compound based on the annual Net Sales of each Product, which royalties will be calculated by multiplying Net Sales by the royalty rate set forth in the following schedule: [ * ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS AMENDED.

  • As of late, the powder dosage form was applied for some poorly soluble drugs, for example, scutellarin, naproxen, Novartis Compound A, itraconazole, and bexarotene.

  • This is consistent with our analytical results that supply shocks are always destabilizing with higher price flexibility while higher flexibility is stabilizing in the case of demand shocks.

  • See "Products Under Development - Cancer - ISIS 3521; ISIS 5132." Novartis will pay Isis royalties on the sale of any Novartis Compound.

  • Any Inactive Compounds, Abandoned Compounds and Returned Compounds shall be available to CombiChem (except for any pre-existing Novartis Compound) and Novartis for any purpose following the designation of a Collaboration Compound as an Inactive Compound or Returned Compound.

  • For the first EDC, and for each CDC and each Product being or containing a Novartis Compound, Novartis shall pay Versicor each of the milestone payments set forth below at the time of their first achievement: [ * ] [ * ] provided, however, that if a Novartis Compound pursuant to this subsection (b) is abandoned during development after one or more of the milestone payments B., C., or D.

  • For the avoidance of doubt, Array shall not have any rights hereunder to pursue, and Novartis shall not have any obligations to permit, clinical trials of Binimetinib in combination with any Novartis Compound other than the Novartis Pipeline Agents.

  • CombinatoRx shall not use any Novartis Compound included in the Library other than pursuant to the Research Collaboration.

  • First compound to reach EDC status (one-time payment only, i.e. payable only for the first Novartis Compound to achieve this milestone) $[ ]* ---------------------------------------------------------------------------------------------------------- B.


More Definitions of Novartis Compound

Novartis Compound means those Compounds contributed to the Library by Novartis as of the Effective Date and during the Collaboration Term as set forth on Schedule C. The composition and representation of Novartis Compounds contributed to the Library shall be at Novartis’ sole discretion. For purposes of clarity, each Novartis Compound shall either be a Novartis Protected Compound or a Novartis Tool Compound.
Sample 1
Novartis Compound means a Licensed Compound that was discovered by Novartis prior to the Effective Date or outside of activities conducted pursuant to this Agreement.
Sample 1
Novartis Compound means a chemical compound that is proprietary to Novartis or whose use or manufacture is proprietary to Novartis or its Affiliates.
Sample 1

Related to Novartis Compound

  • Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).

  • Licensed Compound means [***].

  • Lead Compound means any compound of lead other than galena which, when treated in the manner described below, yields to an aqueous solution of hydrochloric acid a quantity soluble lead compound exceeding, when calculated as lead monoxide, five percent of the dry weight of the portion taken analysis.

  • Licensed Compounds means any EZH2 Compound(s) that is:

  • Compound means the taking of two or more ingredients and fabricating them into a single

  • Back-Up Compound means, with reference to any particular Development Candidate or Drug Product Candidate, a Compound which (a) has the same principal mode of action (i.e., Potentiator or Corrector) as that Development Candidate or Drug Product Candidate; and (b) was among the group of Compounds, identified by VERTEX as potential additional lead molecules having the same principal mode of action, from which the Development Candidate was selected.

  • Novartis shall have the meaning set forth in the Preamble.

  • GSK has the meaning set forth in the preamble.

  • Collaboration Product means any pharmaceutical product in finished form that contains a Collaboration Compound, either as the sole active ingredient or in combination with one or more other active ingredients, and all present and future formulations, dosages and dosage forms thereof.

  • Collaboration Target means the Initial Collaboration Targets set forth on Exhibit F and any Additional Target or Substitute Target that is selected in accordance with Section 3.3 of this Agreement.

  • Hemp product means the same as that term is defined in § 3.2-4112.

  • BMS means the Company, all related companies, affiliates, subsidiaries, parents, successors, assigns and all organizations acquired by the foregoing.

  • Merck has the meaning set forth in the preamble.

  • Compounds means a small molecule HMT inhibitor.

  • Product Candidate means each of MYO-101, MYO-102, MYO-103, MYO-201 and MYO-301, as defined on Exhibit B, in each case in any form or formulation.

  • Diagnostic Product means any test or assay for diagnosing or detecting a disease, disorder, medical condition, or symptom.

  • Licensed Product means any pharmaceutical product containing a Licensed Compound (alone or with other active ingredients), in all forms, presentations, formulations and dosage forms.

  • Development Candidate means a Compound that meets the Development Candidate Criteria for the initiation of a Development Program for the treatment of CF, and which is the subject of a notice from Vertex to CFFT that Vertex intends to commence formal pre-clinical development of the Compound in the Field pursuant to the provisions of Section 3.1 hereof.

  • Biosimilar Product means, with respect to a Licensed Product in any country, any biosimilar product sold by a Third Party not authorized by or on behalf of Celgene, its Affiliates or Sublicensees, (a) that is a biosimilar biological product, as defined in 21 USC 379j-51 (or any successor or replacement thereof), a similar biological medicinal product, as defined in Annex I to Directive 2001/83/EC (or any successor or replacement thereof), or any similar biosimilar or generic product under the Laws of any country or jurisdiction, or (b) regarding which Regulatory Approval is obtained by referencing Regulatory Data of such Licensed Product.

  • Biological product means a virus, therapeutic serum, toxin, antitoxin, vaccine, blood, blood component or derivative, allergenic product, protein other than a chemically synthesized polypeptide, or analogous product, or arsphenamine or any derivative of arsphenamine or any other trivalent organic arsenic compound, applicable to the prevention, treatment, or cure of a disease or condition of human beings.

  • Biological Samples means any physical samples obtained from Study Participants in accordance with the Protocol for the purposes of the Study.

  • Drug Substance means an active ingredient that is intended to furnish pharmacological activity or other direct effect in the diagnosis, cure, mitigation, treatment, or prevention of disease or to affect the structure or any function of the human body, but does not include intermediates used in the synthesis of such ingredient.

  • Antibody means a molecule or a gene encoding such a molecule comprising or containing one or more immunoglobulin variable domains or parts of such domains or any existing or future fragments, variants, modifications or derivatives thereof.

  • ISIS means the department’s individualized services information system.